We identified a de novo missense mutation (G375D) in the gephyrin gene (GPHN) in a patient with epileptic encephalopathy resembling Dravet syndrome. This evidence concerns the gene GPHN and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.